{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:01:22Z","timestamp":1773280882542,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.4158\/ep.13.3.232","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:46:55Z","timestamp":1365198415000},"page":"232-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Bisphosphonates and Osteonecrosis of the Jaw: A Retrospective Study"],"prefix":"10.1016","volume":"13","author":[{"given":"Omar M.","family":"Murad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surender","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal F.","family":"Farag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena A.","family":"Guber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.13.3.232_bb0005","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg."},{"key":"10.4158\/EP.13.3.232_bb0010","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg."},{"key":"10.4158\/EP.13.3.232_bb0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bis-phosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg."},{"key":"10.4158\/EP.13.3.232_bb0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5694\/j.1326-5377.2005.tb06761.x","article-title":"Bisphosphonates and avascular necrosis of the jaw: a possible association","volume":"182","author":"Carter","year":"2005","journal-title":"Med J Aust."},{"key":"10.4158\/EP.13.3.232_bb0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5694\/j.1326-5377.2005.tb06762.x","article-title":"Bisphosphonates and osteonecro-sis of the jaw","volume":"182","author":"Purcell","year":"2005","journal-title":"Med J Aust."},{"issue":"4 Suppl","key":"10.4158\/EP.13.3.232_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.47102\/annals-acadmedsg.V33N4p48S","article-title":"Bisphosphonates\u2014a word of caution","volume":"33","author":"Robinson","year":"2004","journal-title":"Ann Acad Med Singapore."},{"key":"10.4158\/EP.13.3.232_bb0035","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1503\/cmaj.050640","article-title":"Patients receiving intravenous bisphospho-nates should avoid invasive dental procedures","volume":"172","author":"Wooltorton","year":"2005","journal-title":"CMAJ."},{"key":"10.4158\/EP.13.3.232_bb0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5694\/j.1326-5377.2005.tb07172.x","article-title":"Bisphosphonate-induced osteonecrosis of the jaw requires early detection and intervention","volume":"183","author":"Gibbs","year":"2005","journal-title":"Med J Aust."},{"key":"10.4158\/EP.13.3.232_bb0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","article-title":"Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases","volume":"34","author":"Bagan","year":"2005","journal-title":"J Oral Pathol Med."},{"key":"10.4158\/EP.13.3.232_bb0050","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-051X.2005.00842.x","article-title":"Osteonecrosis of the jaws in periodontal patients with a history of bisphos-phonates treatment","volume":"32","author":"Ficarra","year":"2005","journal-title":"J Clin Periodontol."},{"key":"10.4158\/EP.13.3.232_bb0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/sarh.2002.33724b","article-title":"Pathogenesis and natural history of osteonecrosis","volume":"32","author":"Assouline-Dayan","year":"2002","journal-title":"Semin Arthritis Rheum."},{"key":"10.4158\/EP.13.3.232_bb0060","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.joms.2004.04.007","article-title":"Osteonecrosis: a multifactorial etiology","volume":"62","author":"McMahon","year":"2004","journal-title":"J Oral Maxillofac Surg."},{"key":"10.4158\/EP.13.3.232_bb0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer."},{"key":"10.4158\/EP.13.3.232_bb0070","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","article-title":"Osteonecrosis of the jaws associated with cancer chemotherapy","volume":"61","author":"Wang","year":"2003","journal-title":"J Oral Maxillofac Surg."},{"key":"10.4158\/EP.13.3.232_bb0075","first-page":"111","article-title":"Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy","volume":"71","author":"Melo","year":"2005","journal-title":"J Can Dent Assoc."},{"key":"10.4158\/EP.13.3.232_bb0080","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.4158\/EP.13.3.232_bb0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates [with discussion]","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.13.3.232_bb0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.96.1.133","article-title":"Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro","volume":"96","author":"Fisher","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.4158\/EP.13.3.232_bb0095","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","article-title":"New insights into the molecular mechanisms of action of bisphosphonates","volume":"9","author":"Rogers","year":"2003","journal-title":"Curr Pharm Des."},{"key":"10.4158\/EP.13.3.232_bb0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/147323000303100614","article-title":"Suppression of alveolar bone resorption by etidronate treatment for periodontal disease: 4- to 5-year follow-up of four patients","volume":"31","author":"Takaishi","year":"2003","journal-title":"J Int Med Res."},{"key":"10.4158\/EP.13.3.232_bb0105","first-page":"5","article-title":"The effect of alen-dronate sodium on alveolar bone loss in periodontitis (clinical trial)","volume":"5","author":"El-Shinnawi","year":"2003","journal-title":"J Int Acad Periodontol."},{"key":"10.4158\/EP.13.3.232_bb0110","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1902\/jop.2001.72.2.204","article-title":"Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: a randomized, placebo-controlled trial","volume":"72","author":"Rocha","year":"2001","journal-title":"J Periodontol"},{"key":"10.4158\/EP.13.3.232_bb0115","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.gme.0000184421.50696.34","article-title":"Periodontal assessment of postmenopausal women receiving risedronate","volume":"12","author":"Palomo","year":"2005","journal-title":"Menopause."},{"key":"10.4158\/EP.13.3.232_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1902\/jop.2000.71.2.279","article-title":"Alveolar bone response to submerged bisphosphonate-complexed hydroxyapatite implants","volume":"71","author":"Denissen","year":"2000","journal-title":"J Periodontol."},{"key":"10.4158\/EP.13.3.232_bb0125","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1902\/jop.2002.73.7.813","article-title":"Bisphosphonates and periodontics: potential applications for regulation of bone mass in the periodontium and other therapeutic\/diagnostic uses","volume":"73","author":"Tenenbaum","year":"2002","journal-title":"J Periodontol."},{"key":"10.4158\/EP.13.3.232_bb0130","first-page":"2155","article-title":"The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis: a randomized clinical study","volume":"87","author":"Lai","year":"2005","journal-title":"J Bone Joint Surg Am."},{"key":"10.4158\/EP.13.3.232_bb0135","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/rheumatology\/keh481","article-title":"Efficacy of alen-dronate, a bisphosphonate, in the treatment of AVN of the hip: a prospective open-label study [erratum in Rheumatology (Oxford). 2005;44:569]","volume":"44","author":"Agarwala","year":"2005","journal-title":"Rheumatology (Oxford)."},{"key":"10.4158\/EP.13.3.232_bb0140","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Narrative (corrected) review: bisphosphonates and osteonecrosis of the jaws [erratum in Ann Intern Med. 2006;145:235]","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.13.3.232_bb0145","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.joms.2004.03.005","article-title":"Osteonecrosis and bisphosphonates: correlation versus causation","volume":"62","author":"Schwartz","year":"2004","journal-title":"J Oral Maxillofac Surg."},{"key":"10.4158\/EP.13.3.232_bb0150","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.4065\/81.8.1100","article-title":"Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy","volume":"81","author":"Kademani","year":"2006","journal-title":"Mayo Clin Proc."},{"key":"10.4158\/EP.13.3.232_bb0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.joms.2003.05.024","article-title":"Ultrasound measurement of mandibular arterial blood supply: techniques for defining ischemia in the pathogenesis of alveolar ridge atrophy and tooth loss in the elderly?","volume":"63","author":"Eiseman","year":"2005","journal-title":"J Oral Maxillofac Surg."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20418294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20418294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/9172R1N54UN20441.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:47:00Z","timestamp":1761515220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20418294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S1530891X20418294"],"URL":"https:\/\/doi.org\/10.4158\/ep.13.3.232","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonates and Osteonecrosis of the Jaw: A Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.13.3.232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}